A detailed history of Parkwood LLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Parkwood LLC holds 13,250 shares of LEGN stock, worth $530,397. This represents 0.07% of its overall portfolio holdings.

Number of Shares
13,250
Previous 13,562 2.3%
Holding current value
$530,397
Previous $761,000 22.86%
% of portfolio
0.07%
Previous 0.07%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$39.5 - $57.22 $12,324 - $17,852
-312 Reduced 2.3%
13,250 $587,000
Q1 2024

May 15, 2024

BUY
$55.06 - $69.99 $37,330 - $47,453
678 Added 5.26%
13,562 $761,000
Q4 2023

Feb 14, 2024

SELL
$57.25 - $69.74 $39,101 - $47,632
-683 Reduced 5.03%
12,884 $775,000
Q3 2023

Nov 14, 2023

BUY
$63.16 - $76.5 $573,998 - $695,232
9,088 Added 202.9%
13,567 $911,000
Q2 2023

Aug 14, 2023

BUY
$46.28 - $75.01 $207,288 - $335,969
4,479 New
4,479 $309,000

Others Institutions Holding LEGN

About Legend Biotech Corp


  • Ticker LEGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 167,403,008
  • Market Cap $6.7B
  • Description
  • Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...
More about LEGN
Track This Portfolio

Track Parkwood LLC Portfolio

Follow Parkwood LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parkwood LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parkwood LLC with notifications on news.